tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

BYSI Stock Latest News

BeyondSpring reports first patient dosed with pembrolizumab, plinabulin plus EP
The FlyBeyondSpring reports first patient dosed with pembrolizumab, plinabulin plus EP
30d ago
BYSI
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
PremiumPress Releases
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
30d ago
BYSI
BeyondSpring Announces Executive Leadership Change
PremiumCompany Announcements
BeyondSpring Announces Executive Leadership Change
1M ago
6K
BYSI
BeyondSpring regains compliance with Nasdaq minimum bid price rule
PremiumThe Fly
BeyondSpring regains compliance with Nasdaq minimum bid price rule
2M ago
BYSI
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
PremiumPress Releases
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
3M ago
BYSI
BeyondSpring reports Nasdaq delinquency notice for late filing
PremiumThe FlyBeyondSpring reports Nasdaq delinquency notice for late filing
3M ago
BYSI
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
PremiumPress Releases
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
4M ago
BYSI
BeyondSpring receives noncompliance notification from Nasdaq
PremiumThe Fly
BeyondSpring receives noncompliance notification from Nasdaq
4M ago
BYSI
BeyondSpring presents new data on plinabulin’s immunomodulating activity
PremiumThe Fly
BeyondSpring presents new data on plinabulin’s immunomodulating activity
6M ago
BYSI
BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors
PremiumPress Releases
BeyondSpring Presents Poster Highlighting Preclinical and Clinical POC Immunomodulating Activity of Plinabulin Inducing Dendritic Cell Maturation and Re-sensitization in Immunotherapy Refractory Tumors when Combined with Radiation and PD-1/PD-L1 Inhibitors
6M ago
BYSI
BeyondSpring presents poster on plinabulin’s anti-cancer efficacy
PremiumThe Fly
BeyondSpring presents poster on plinabulin’s anti-cancer efficacy
6M ago
BYSI
BeyondSpring regains compliance with Nasdaq minimum bid price rule
PremiumThe Fly
BeyondSpring regains compliance with Nasdaq minimum bid price rule
6M ago
BYSI
BeyondSpring’s Seed Therapeutics discloses IND candidate, ST-00937
PremiumThe FlyBeyondSpring’s Seed Therapeutics discloses IND candidate, ST-00937
6M ago
BYSI
SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium
PremiumPress Releases
SEED Therapeutics Discloses Novel Molecular Glue IND Candidate for Cancer at “Targeted Protein Degradation Think Tank” Symposium
6M ago
BYSI
SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors
PremiumPress Releases
SEED Therapeutics, a BeyondSpring Subsidiary, Appoints Mr. Ko-Yung Tung to the Board of Directors
6M ago
BYSI
BeyondSpring receives noncompliance notification from Nasdaq
PremiumThe Fly
BeyondSpring receives noncompliance notification from Nasdaq
7M ago
BYSI
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
PremiumPress Releases
BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements
7M ago
BYSI
BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting
PremiumPress Releases
BeyondSpring and Leading Cancer Center to Present Poster at SITC’s 38th Annual Meeting
7M ago
BYSI
BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference
PremiumPress Releases
BeyondSpring to Participate in the R.W. Baird’s 2023 Global Healthcare Conference
8M ago
BYSI
BeyondSpring’s SEED Therapeutics appoints Tai to board of directors
PremiumThe FlyBeyondSpring’s SEED Therapeutics appoints Tai to board of directors
10M ago
LLY
BYSI
BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting
PremiumPress Releases
BeyondSpring and Leading Cancer Center to Present Poster at 2023 ASCO Annual Meeting
11M ago
BYSI
BeyondSpring price target lowered to $1.25 from $4 at Baird
PremiumThe Fly
BeyondSpring price target lowered to $1.25 from $4 at Baird
12M ago
BYSI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >